British pharmaceutical giant AstraZeneca signed a landmark agreement on Friday to invest $2.5 billion in Beijing over the next five years, signaling the multinational's confidence in the world's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback